Enhertu approved in Canada as the first and only HER2-directed therapy for patients with HR-positive...

Marketing approval obtained in China for Meiyouheng (Becotatug Vedotin injection)

GSK’s B7-H3-targeted antibody-drug conjugate, GSK’227, receives orphan drug designation in the EU

Alphamab Oncology announces biparatopic HER2-targeting ADC JSKN003 was granted fast track designation by FDA for...

Cellectar Biosciences receives rare pediatric disease designation from U.S. FDA for Iopofosine I 131 in...

GSK acquires exclusive rights from Syndivia for antibody-drug conjugate (ADC) in prostate cancer